Intellectual Property Litigation partners recognized for brand-side pharmaceutical trial prowess.
Kenneth Schuler, a member of Latham & Watkins' Intellectual Property Practice, is a seasoned patent litigator, with a particular emphasis in pharmaceutical patent litigation involving claims arising under the Hatch-Waxman Act. Mr. Schuler joined Latham in 1994 after serving as a judicial clerk to Judge James B. Loken, United States Court of Appeals for the Eighth Circuit. Since joining Latham, Mr. Schuler has acquired extensive litigation experience in federal and state courts, as well as in commercial arbitrations. He has extensive trial experience, having been admitted to the Trial Bar of the Northern District of Illinois in 2002.
Mr. Schuler has handled a number of pharmaceutical patent-related cases for clients such as Mallinckrodt Pharmaceuticals, Cadence Pharmaceuticals, Eagle Pharmaceuticals, Endo Pharmaceuticals, Roxane Laboratories, Actavis, Orchid Chemicals & Pharmaceuticals, Boehringer-Ingelheim GmbH, Alvogen, Par Pharmaceuticals, and Roxane Laboratories. He also has substantial experience litigating other intellectual property matters, including patent, trade secrets, and trade dress suits, representing Overhead Door, ADA Carbon Solutions, Neuromedical Systems, Inc., and Libbey Glass, Inc., with respect to myriad technologies, including activated carbon, manufacturing, barrier system operators, oxygen barrier plastic containers, ATM networks, mass spectrometers, and diagnostics. In addition, Mr. Schuler has extensive experience involving securities, class action, and complex commercial litigation, handling such matters for U.S. Bancorp, Jefferies & Company, Nissan, and National Presto Industries. Intellectual Asset Management magazine named Mr. Schuler to the IAM Patent 1000 from 2014-2021. He was named a Law360 MVP for Life Sciences in 2020.